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Abstract
The HIV-1 virus can enter a dormant state and become inactive, which reduces
accessibility by antiviral drugs. We approach this latency problem from an
unconventional point of view, with the focus on understanding how intrinsic chemical
noise (copy number fluctuations of the Tat protein) can be used to assist the activation
process of the latent virus. Several phase diagrams have been constructed in order to
visualize in which regions of the parameter space noise can drive the activation process.
Essential to the study is the use of a hyperbolic coordinate system, which greatly
facilitates quantification of how the various reaction rate combinations shape the noise
behavior of the Tat protein feedback system. We have designed a mathematical manual
of how to approach the problem of activation quantitatively, and introduce the notion
of an “operating point” of the virus. For both noise-free and noise-based strategies we
show how operating point off-sets induce changes in the number of Tat molecules. The
major result of the analysis is that for every noise-free strategy there is a noise-based
strategy that requires lower dosage, but achieves the same anti-latency effect. It
appears that the noise-based activation is advantageous for every operating point.
Introduction
HIV-1 latency is a serious problem that prevents eradication of the virus
Human immunodeficiency virus 1 (HIV-1), initially reported nearly 30 years ago, repre-
sents a major global health problem with millions of people infected [1,2]. One of the
biggest problems with HIV-1 is that the virus can enter a dormant state and effectively
“hide” from drug cocktails that are therapeutically administered. Several reviews have
been written on the subject [3-13]. Latent viral reservoirs can persist for many years. Once
a therapy is interrupted, the latent reservoirs remain as the source of eventually renewed
infection. This behaviour has been identified as the key problem in eradicating HIV-1.
There are many reservoirs, e.g., cell types, in the body that can harbor the latent virus.
CD4+ T-cells have been identified as one of the largest pools of the viral DNA. This is also
one of the best characterized reservoirs [5]. Once a T-cell is infected, it can either become
activated and produce new virus particles that will infect other cells, or it can enter an
inactive state. In the inactive (latent) state the transcription of the viral DNA is silenced,
despite the fact that the viral RNA has been reversely transcribed and inserted into the
host DNA.
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The process of entry into the latent state is rather complex since it is controlled by
a sizeable number of processes which need to occur nearly at the same time [8-10,13].
There is a relatively low percentage of latently infected T-cells, being roughly one per
106, though the frequency can be lower [13]. This also suggests that once the latent state
is established it remains very stable, and spontaneous activation events are very rare. In
order to activate a latent cell, the inactive cellular processes need to be reactivated, which
is not likely to occur simultaneously. A large number of studies have been performed in
the past with the goal to find a way of reliably activating the latent virus, as reviewed in
[3-13].
The mechanisms responsible for the maintenance of the HIV-1 latency work mostly at
the molecular level. Processes such as chromatin control, a shortage of host transcrip-
tion factors that initiate transcription, the presence of molecules that slow down (or even
block) polymerase elongation, transcriptional interference, DNA methylation, and insuf-
ficient transport of viral mRNA from the nucleus to the cytoplasm are some prominent
examples. All known mechanisms have been reviewed in detail, for example in [8-10,13].
A small number of studies focused on the role of chemical (intrinsic) noise in establish-
ing the latent state [14-17]. A generic conclusion extracted from these studies is that noise
is detrimental for the latency decision. Noise comes from fluctuations in copy numbers
of the proteins that are involved in the latency control. The level of noise in the system is
partially modulated by host factors (proteins that are present in healthy cells) and partially
with virus specific factors (proteins encoded by viral genetic machinery). Noise makes
the latency decision stochastic (unpredictable) and the literature suggests that the noise
driven inactivation occurs spontaneously.
In the present study the focus is placed on understanding how noise can be manipu-
lated to reverse the latency decision, i.e., to drive the activation process. This idea is fully
in line with several previous findings and suggestions in the literature. For example, it has
been clearly appreciated that noise plays a role in various cellular decision making pro-
cesses [18,19], but the idea to use noise to steer cell fate decisions has never been seriously
explored. It has been argued, merely on a general basis, that one should strive to control
noise better in order to steer cell fate decisions [19]. In the context of the HIV activation
it has been found that altering noise of the HIV genetic machinery can bias virus decision
making towards productive replication or latency [20].
In our study the focus is on finding ways to manipulate noise in order to specifically
facilitate the productive activation, which could become the foundation of medical treat-
ment strategies in the future. To our knowledge, this way of approaching the eradication
of the latent virus has not yet been much discussed in the literature.
The first goal of this study is to identify regions in parameter space where noise greatly
influences the dynamics. We investigate fluctuations of copy numbers of several key pro-
teins that are involved in the maintenance of the latent state of infected cells. Based on
these insights, the second goal is to identify suitable medical strategies that can be used to
harvest noise in order to achieve more efficient activation. These intuitive considerations
will be addressed in a quantitative way by means of a rigorous mathematics.
The Tat feedback loop is a main source of noise driving the activation of the latent virus
TheTat feedback loop has been identified as an important part of theHIV gene expression
machinery, reviewed in [3-5,7] and others. The main biological function of the Tat loop is
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to accelerate viral RNA production which further increases the number of viral particles
in the infected cell. The presence of Tat molecules in the cell increases the transcription
rate by roughly two orders of magnitude. This normally leads to cell lysis and continued
infection of other cells. A lack of Tatmolecules in latently infected cells has been identified
as a strong barrier to activation of the latent cell [8-10,13].
Interestingly, the loop appears to be important for noise driven entry into the latent
state [14-17]. If viral DNA integrates into regions of high basal transcription then noise
does not play such a big role. However, if it integrates in regions of low basal tran-
scription, then the positive feedback loop can amplify noise effectively and produce
bursts of activity. In such a way the fate of the cell is determined in a stochas-
tic manner, as shown in [14,15]. Such behavior splits the typical low transcription
isogenic cell population into two groups. In the first group the Tat feedback loop pro-
duces new Tat particles (the “on” state). In the second group the Tat feedback loop
is inactivated (the “off” state). This phenomenon was termed the phenotypic bifur-
cation (PheB). A series of carefully designed experiments were performed [14] to
show that such behavior is indeed a product of intracellular noise, and is indepen-
dent from extracellular perturbations. The possibility of a spontaneous latency decision
caused by uncontrollable fluctuations of the Tat copy number has been clearly demon-
strated.
Current anti-latency treatments need to be improved
Even though several anti-latency drugs have been investigated, it is not clear how to
administer them efficiently. For example, there is no consensus whether they should
be administered aggressively (all at once), by repeated injection of smaller amounts, or
constantly administered over a longer time period [4,5,21,22].
It is generally agreed upon that due to potential side effects of the treatment (e.g. toxi-
city), minimal dosages are preferable. A convincing argument for administering Minimal
dosages is that too large amounts of the activation drug might release the virus beyond
control, such that the usual highly active antiretroviral therapy (HAART) cannot contain
it any longer [21]. Moreover, there are viral reservoirs, e.g., the brain, that are not easily
accessible by HAART. In such organs it is very important to activate the virus gradually.
Clinical studies show that a global T-cell activation cannot eradicate the virus. Instead,
it causes unwanted side effects [22]. An additional problem is that many of the activating
agents are generic to a wide range of gene regulation processes; administering them is
expected to show severe toxicity in the host. Thus the reduction of the dosage of anti-
latency drugs appears desirable. In this context, noise-driven activation could be highly
beneficial.
Intrinsic fluctuations in protein copy numbers could be used to achieve more efficient
activation
A therapy can be envisionedwhere several types of drugs work in synergy with the specific
aim of moving the operating point of the virus into a noisy region, where the frequency
of spontaneous virus activation would increase. Such therapy could be sustained for a
longer time since, presumably, lower dosages of anti-latency drugs could be used. Target-
ing fluctuations in Tat copy number is very natural in this context, since the Tat protein is
an essential part of the gene transcription machinery which produces new viral particles.
Konkoli and Jesorka Theoretical Biology andMedical Modelling 2013, 10:16 Page 4 of 28
http://www.tbiomed.com/content/10/1/16
Fluctuations in Tat copy number have the potential to drive the activation. The up
to date understanding of the feedback loop is that Tat controls transcriptional elon-
gation rather than initiation. However, it seems that these two processes cannot be
clearly separated, as it has been shown that an exogenous injection of Tat can activate
the latent cell [14,23-27]. We note that a study on mice [25] showed no obvious side
effects.
It is somewhat surprising that exogenous administration of Tat can in fact have a posi-
tive effect on the activation of infected cells. The lack of Tat molecules is just one of the
many barriers to activation. If the transcription of the viral DNA is also blocked by other
mechanisms that are not controlled by the Tat protein, the injection of exogenous Tat
should not speed up the transcription process automatically. In fact, there are also cases
where Tat by itself cannot reactivate the virus [28].
This supports a notion that in latently infected cells the transcription system is in a
rather labile state, and that the factors affecting the transcription process do not work
strictly in a binary on-off fashion. Such a system could be activated by spontaneous fluc-
tuations in Tat copy number. Based on this insight, in the next section we will construct a
mathematical machinery to identify useful strategies to achieve noise-assisted activation
of the virus.
Amathematical manual for the design of noise-based activation strategies
The central idea in the subsequent discussions is the concept of the “operating point”
of the virus. The term will refer to a particular choice of the parameters that define the
dynamics of the system, i.e., the virus and the cell it infects. In fact, one of the diffi-
culties in combating HIV is that the integration of the virus into different sites gives
rise to proviruses that have variable gene expression properties. It is conceivable that
this results in different operating points of the virus. Therefore it is not immediately
clear how a drug designed to achieve noise-based activation at a specific operation
point would work consistently at other operating points. It is important to address this
concern.
The manual we envision must contain a description of how (i) each anti-viral treat-
ment affects an operating point, (ii) how the amounts of administered agents affect the
magnitude of the off-set, and (iii) which anti-latency effect the induced off-set has. If
the operating point of the virus is moved to regions where the latent state is less sta-
ble, the effect of antiviral drugs might be enhanced, which implies reduced dosage
and shortened treatment. Below, each of these key considerations is mathematically
formalized.
Mathematical description of therapies and dosage
Assumption I. The main function of each anti-latency agent is to alter the operating point
of a virus:Assume that the virus is at an operating point λ∗, being a list of relevant param-
eters that describe the reaction system (the latent cell). If a certain amount of anti-latency
agents is administered then this will off-set the operating point of the virus by −→λ and
move it to a new operating point λ∗ + −→λ. Thus mathematically, with every activation
strategy one needs to associate the related displacement of the operating point it induces.
It is possible that a treatment generates always the same displacement regardless of the
operating point of the virus, but this does not necessarily need to be the case.
Konkoli and Jesorka Theoretical Biology andMedical Modelling 2013, 10:16 Page 5 of 28
http://www.tbiomed.com/content/10/1/16
In this abstract sense a treatment of the HIV latency is a vector mapping M from the
space of operating points λ into the space of operating point off-sets
−→
λ = M(−→Q, λ) (1)
where the vector −→Q lists the amounts of anti-latency agents that are administered. This
quantity can be viewed as an additional parameterization of the mapping. It is the same
for every operating point. The condition
M(−→Q = 0, λ) = (0, 0, 0) (2)
should be always satisfied, i.e., with nothing administered no operating point off-set is
induced.
Assumption II. The size of the operating point off-set depends on the dosage: The size
of the off-set −→λ, to be denoted by ‖−→λ‖, is related to the amount of agents that are
administered, to be denoted by |−→Q|. Clearly, these two quantities should be related. The
simplest and rather general way to proceed is to assume that they are proportional to each
other
|−→Q| = const‖−→λ‖ (3)
where the size of the off-set is defined as
‖−→λ‖ =
√
λ2v + λ2u + λ2 (4)
being the standard Cartesian norm of the vector −→λ.
A possibility is to define |−→Q| as the sum of its components. Another, more practically
relevant, definition could involve some toxicity measure
|−→Q| = TM(−→Q) (5)
To avoid working with complicatedmetric spaces and projection procedures, the simplest
possible relationship in the form of a proportionality law will be assumed.
Probability of activation and related observables
The central quantity of interest is the probability of the activation of a latent cell in an
observation interval t0 < t′ < t, to be denoted by P(t0, t).
Assumption III. Off-sets should be induced to reduce the survival probability of a latent
virus. In strict mathematical terms P(t0, t) is a complex functional on the space of trajec-
tories (histories). A history of the latent cell is defined as a set of individual trajectories
for each particle type that define the biochemical content of the cell
{
n1(t′), n2(t′), · · · , nN (t′)|t0 ≤ t′ ≤ t
}
(6)
where ni(t′) for i = 1, 2, · · · ,N are copy numbers of relevant reactants (e.g. proteins) at
time t′.
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Intuitively, one expects that not all details of trajectories are important and that the
activation probability depends strongly on a distinct feature of a history quantified by an
observable (quantifier) ,
P(t0, t) = () (7)
The observable  is a functional on the space of histories and () is a real valued func-
tion. Two examples of  will be discussed later. If the observable  is chosen well, the
activation probability should depend on  in a threshold like manner,
() ≈
{
0  < ∗
1  ≥ ∗ (8)
where ∗ is a constant.
The noise-free and noise-based activation concepts
Since trajectories are stochastic, the variable  is also stochastic and can be described by
some probability distribution function (). Assume that two types of treatments have
been designed which adjust the operating point of the stable latent virus (OP0) so that
the respective distributions for  are obtained as depicted in Figure 1 (OP1, OP2). The
two distinct scenarios will be referred to as the “noise-free” (NFA) and the “noise-driven
(based)” (NBA) activations. The distributions are characterized by their respective means
(¯1, ¯2) and standard deviations (1, 2). The NFA activates with absolute certainty
since ¯2 ± 2 
 ∗. The NBA is less successful, since there are many instances where
¯1 < ∗ but due to frequent fluctuations the threshold is reached often and ¯1 + 1 ≈
∗. Thus in strict mathematical terms, a noise-free treatment ignores fluctuations and
aims to establish an operating point such that ¯ ≈ ∗. A noise-based treatment does not
achieve the equality but there are frequent fluctuations that do, and ¯ +  ≈ ∗
Workings and effects of noise-free therapies
The purpose of a noise-free (NF) therapy MNF(−→Q, λ∗) is to increase the quantify
NF(λ∗) ≡ ¯(λ∗) (9)
as much as possible. Under the influence of the treatment with a small dosage the
expected change of this quantity
NF(
−→
λ) ≡ NF(λ∗ + −→λ) − NF(λ∗) (10)
can be approximated by
NF(
−→
λ) ∼ χ∗ • −→λ (11)
where
χ∗ = ∇λNF(λ)|λ=λ∗ (12)
is the gradient computed at the operating point λ∗.
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Very likely, due to experimental constraints, not all off-sets can be realized. In an ideal
situation where all off-sets can be induced, there is a class of treatments which are the
most efficient. Such therapies should induce the off-set in the direction of the gradient
χˆ∗ = χ∗‖ χ∗‖ (13)
as
−→
λ = MNF(−→Q, λ∗) ∝ χˆ∗ (14)
Such a treatment will be referred to as optimal noise-free.
Workings and effects of noise-based treatments
For a noise-based treatment MNB(˜Q, λ∗) the goal is to increase
NB(λ∗) ≡ ¯(λ∗) + κ(λ∗) (15)
where variable κ quantifies the typical size of a fluctuation. For a small dosage,
the expected change of this quantity
NB(
−→
λ) ≡ NB(λ∗ + −→λ) − NB(λ∗) (16)
can be approximated by
NB(
−→
λ) ∼ ψ∗ • −→λ (17)
where
ψ∗ = ∇λNB(λ)|λ=λ∗ (18)
Figure 1 Themeaning of the noise-free and the noise-based activations. The figure illustrates the
meaning behind the noise-free and noise-based activations. All graphs were drawn by hand. i() with
i = 0, 1, 2 are distribution functions for the observable  for three systems in three operating points: the
latent cell i = 0, the cell that has been activated using the noise-based therapy (i = 1), and the cell that has
been activated using noise-free therapy (i = 2). ¯i and i are the means and the standard deviations. The
noise free therapy (NFT) shifts the operating point of the virus from the stable (latent) operating point OP0 to
the operating point OP2. This almost certainly activates the virus since ¯2 − κ2 
 ∗ . The noise-based
therapy (NBT) induces the shift from the OP0 to the operating point OP1 where the activation is less certain
but still possible since the tail of the 1 enters into the activation region and ¯1 + κ1 ≈ ∗ . Variable κ is a
numerical factor close to 1.
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It is useful to partition this gradient further into a noise-free part and a noise-related
part
ψ∗ = χ∗ + κν∗ (19)
where the noise related-part is given by
ν∗ = ∇λ(λ)|λ=λ∗ (20)
The precise value for κ depends on the character of the particle number distribution
function and the confidence interval, but in here it will be taken as κ ∼ 1 for simplicity
reasons. Note that the effects of noise can be shut-off by taking κ = 0.
Among all noise-based (NB) treatments a class of most efficient treatments exist, which
induce the off-set in the direction
˜λ = MNB(˜Q, λ∗) ∝ ψˆ∗ (21)
where
ψˆ∗ =
ψ∗
‖ ψ∗‖
(22)
Such a treatment will be referred to as optimal noise-based.
The dose reduction coefficient can be used to quantify at which operating points the
noise-based treatment is useful
Of particular interest is to find a proper combination of drugs that can achieve a maximal
effect with a minimal dosage. We compare two arbitrary procedures MNF(−→Q, λ∗) and
MNB(˜Q, λ∗) with the requirement that
NF(
−→
λ) = NB(˜λ) (23)
implying that both therapies induce the same change of the quantities they respectively
try to maximize. The quantities are given in (9) and (15) respectively, and −→λ and ˜λ are
the respective off-sets. For a given −→λ we wish to find the smallest possible vector ˜λ
such that equation (23) holds:
|˜Q| = min ⇔ ‖˜λ‖ = min (24)
If the size of the vector ˜λ is smaller than the size of the vector −→λ then a noise based
therapy with lower dosage is possible.
The minimization problem defined in (23) and (24) can be applied to decide whether
a superior noise-based treatment exists, resulting in a lower dosage. The solution of the
optimization problem is given by
˜λ = ψˆ∗ χ∗ •
−→
λ
‖ ψ∗‖
(25)
where the dot denotes the scalar product. The ratio
(λ∗,−→λ) ≡ ‖˜λ‖‖−→λ‖
= | χ∗ •
−→
λ|
‖ ψ∗‖‖−→λ‖
(26)
will be used to quantify the comparison between the two strategies. This quantity indi-
cates the degree of the dose reduction for the treatment associated with a vector −→λ. It
does not depend on the size of the displacement vector −→λ, only on its direction relative
to the gradient of the mean.
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In the case where the optimal noise-free treatment −→λ is aligned along the gradient of
the mean, the amount of dose reduction becomes
(λ∗) ≡ ‖χ∗‖‖ ψ∗‖
= ‖ χ∗‖‖ χ∗ + κν∗‖ (27)
to be referred to as the dose reduction coefficient. Ideally, (λ∗) < 1 but the opposite is
perfectly possible. When (λ∗) > 1 noise-based therapy simply would not work as well
as its noise-free counterpart.
The space of operating points where a noise-based activation strategy can work
Now themathematical manual will be used to find regions in the space of operating points
of the latent virus where a noise-based activation is effective. To do this we focus on the
Tat feedback loop. It is essential to model the noise of the Tat feedback loop, and to
choose a relevant observable. The loop itself will be modelled in the simplest possible way
as shown in the next subsection. The features of the system we wish to describe and the
related observables are discussed subsequently.
The resistor model of HIV latency
The “resistor model” of the HIV dormancy control has been suggested to explain how
the lack of the Tat molecules maintains (stabilizes) the latent state [14,15]. This simpli-
fied description of the transcription machinery will be used for the theoretical analysis.
The biochemical model [15] consists of entities (or particle types) TatA and TatD which
denote the acetylated and deacetylated form of the Tat molecule respectively. To simply
the notation TatA and TatD will be abbreviated as A and D respectively.
Themodel consists of the following chemical reactions. Each deacetylated Tatmolecule
can get acetylated with rate α,
D α−→ A (28)
and each acetylated Tat molecules can get deacetylated with rate β ,
A β−→ D (29)
Deacetylated Tat molecule decay with rate δ
D δ−→ ∅ (30)
An acetylated Tat molecule works as a transcription factor for the expression (produc-
tion) of an additional TatDmolecule,
A k−→ A + D (31)
It is clear that the model defined above neglects many biochemical details and is far
from complete. For example, the mechanisms listed above are just a subset of all modifi-
cations of the Tat protein that occur in the cell [29]. Furthermore, a weak basal expression
of TatD is continuously occurring [14] but this process will be neglected in the same way
as in [15]. The model does not discriminate between mRNAs and proteins, either.
A class of noise-based activation strategies
The resistor model exhibits two states depending on the choice of the reaction rates. In
the active state the feedback loop dominates the dynamics and all copy numbers increase.
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In the stable (dormant) state, bursts of activity last for a finite period of time during which
the number of TatAmolecules increases, reaches amaximum at t = tmax, and then decays
to zero. Such bursts of activity will be referred to as pulses. A pulse lasts typically for
a time teq. They rarely happen spontaneously and need to be initiated by injection of
deacetylated Tat. This behavior is illustrated in Figure 2.
The stability condition has been formulatedmathematically in [15]. The system is stable
if
αk < βδ (32)
This condition is a fundamental property of the system. It defines the balance between the
processes that produce and destroyTatAmolecules. The system is stable if the production
is slower than the destruction.
The key behavior of the resistor model we wish to exploit is related to pulses of activity.
We investigate a hypothetical situation where Tat molecules are administered weakly at
a constant rate in combination with an anti-viral drug and one or more operation point
off-setting agents. The injection ofTat should trigger repeated pulses of activity. The anti-
viral drug should reduce the copy number of viruses, while the off-setting agents move
the operating point of the virus towards a nosier regime. The role of the off-setting agents
is to boost fluctuations in the Tat expression levels so that the dosage of the anti-viral
drug can be reduced.
Two pulse characteristics as key observables
We now apply the mathematical machinery to compute the dose reduction coefficient for
a wide range of reaction rate parameters (operating points) of the resistor model. It is nec-
essary to identify an observable upon which the activation probability strongly depends.
It will be assumed that the determining observable that governs the activation probability
is the amount of viral mRNAs (proteins) produced by the feedback loop for the duration
Figure 2 The characteristics of a typical pulse. The figure illustrates the key features of the activity pulse.
All graphs were drawn by hand. The pulse lasts roughly teq and attains the maximum at roughly t ≈ tmax.
Additional key quantities of interest are the height of the pulse μmax, fluctuations around the peak described
by the standard deviation σmax, and the surface under the curve. The patterned triangle can be used to
approximate the shape.
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of a single pulse triggered by a single injection of Tat. If there are many viral particles that
are ready for packaging and transport, the latent cell should activate.
The number of tatD mRNAs produced during the activation of the pulse can be com-
puted by investigating how many molecules are produced by the A → A + D channel
during the pulse duration. The expected amount of mRNAs produced in a small time
interval dt is exactly given by k nA(t) dt. Integrating this quantity for the whole pulse
duration gives
PS ∼ kA (33)
whereA
A =
∫ ∞
0
dtnA(t) (34)
is the pulse surface (PS), i.e., the surface under the nA(t) curve (see Figure 2). This sce-
nario will be referred to as the pulse surface-dependent threshold scenario, and when
appropriate quantities computed in this context will be labelled by PS as in the example
above.
There is no explicit experimental evidence that the surface is the one determining factor
that most strongly influences activation. However, this idea is supported by several exper-
imental studies. For example, in the experiment published in [15] it was argued that the
duration of the activity pulse is likely to be important. The strength of the feedback loop
regulates the duration of activity bursts. For less stable states the duration of such bursts
increases dramatically, until they become equally long, and eventually longer than the life-
time of the cell. Furthermore, in [30] it was experimentally shown that a stronger feedback
implies more likely activation. Stronger feedback should correlate with the size of the sur-
faceA. Thus the first observable that will be used to implement the mathematical manual
is the areaA.
Describing the fluctuations of the area A is a very hard mathematical problem, since
computing fluctuations involves the double integral over time of the particle density cor-
relation function. This correlation function cannot be directly computed from lowest
order moments of the particle number distribution function, only numerically at high
computational cost. It is possible to simplify the mathematical treatment by focussing
solely on the pulse height, which is much simpler to describe. Thus an additional observ-
able will be considered, the maximum Tat copy number observed for a given trajectory.
This scenario will be referred to as the concentration-dependent threshold scenario. The
key quantity in this scenario is the pulse height (PH),
PH ∼ nA(tmax) (35)
where nA(t) is the number of A at time t (see Figure 2). The quantities computed in this
context will be labeled by PH as above.
While PH will be primarily used for illustrative purposes to gain qualitative under-
standing, the concentration-dependent threshold scenario does have practical signifi-
cance. One expects that the number of Tat molecules in the cell correlates with the
number of other viral proteins since their expression is encoded in the same gene. In that
sense, high copy numbers of Tat protein should correlate with large activation probability.
There are also some experimental indications in favour of the scenario.
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Although there is no direct evidence that Tat on its own ensures activation, there is
experimental evidence that exogenous injection of Tat can activate the latent cell [25].
Interestingly, there is also a report of the opposite [28]. Moreover, it has been suggested
in several publications that Tat operates in a threshold dependent manner [6,8,31,32], but
there is no direct experimental evidence for that. Interestingly, it is known that the Rev
protein which controls export of viral mRNAs operates in a threshold dependent manner,
and Tat drives the concentration of Rev above the threshold (See [15] for a discussion).
Computation of the dose reduction coefficients for the concentration-dependent
threshold scenario (the pulse height scenario)
The average number of acetylatedTatmolecules at the peakμmax and the related standard
deviation of it σmax are the key quantities that need to be computed. Figure 2 illustrates
the meaning of these quantities. Both have to depend on the parameters that define an
operating point of the latent cell,
μmax = μmax(λ) (36)
σmax = σmax(λ) (37)
The functions μmax(λ) and σmax(λ) will be defined later on.
In this context the following choice for the observables of interest is the most natural:
NF(λ) = μmax(λ) (38)
and
NB(λ) = μmax(λ) + κσmax(λ) (39)
This results is the following dose reduction coefficient computed at an operating point of
interest λ∗:
PH(λ∗) = ‖μ
′∗‖
‖ μ′∗ + κ σ ′∗‖
(40)
where
μ′∗ ≡ ∇λμmax(λ)|λ=λ∗ (41)
and
σ ′∗ ≡ ∇λσmax(λ)|λ=λ∗ (42)
Note that (λ∗) depends on the gradients and not on the values:
μ∗ ≡ μmax(λ∗) (43)
σ∗ ≡ σmax(λ∗) (44)
Computation of the dose reduction coefficients for the pulse-surface dependent threshold
scenario
We try to estimate fluctuations of A from the knowledge of μmax and σmax. The average
surface can be estimated by approximating it with the area of the triangle emphasized in
Figure 2. This area is roughly given by
A(λ) ≈ 12 teq(λ)μmax(λ) (45)
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where teq denotes the average equilibration time of the system. This quantity has to be a
well-defined function of the operating point teq = teq(λ).
The standard deviation of the area is much harder to estimate. A rough estimate for a
typical fluctuation of this surface is given by
δA(λ) ≈ 12
(
teq(λ)δnA(tmax) + δteq(λ)nA(tmax)
)
(46)
where δnA(tmax) ∼ κσmax(λ) is a typical fluctuation of the number of A at t = tmax and
δteq(λ) is the size of a typical fluctuation of the pulse duration. To avoid the mathematical
complexity involved in computing δteq(λ), it will be assumed that this quantity does not
fluctuate.
These assumptions results in the following observable for the noise-free activation
analysis,
NF(λ) ≈ 12 τ(λ)μmax(λ) (47)
and the related noise-corrected quantity is given by
NB(λ) ≈ 12τ(λ)
[
μmax(λ) + κσmax(λ)
]
(48)
The re-scaled equilibration time
τ(λ) = k teq(λ) (49)
measures the ratio between the length of the pulse duration and the time needed to pro-
duce a single tat mRNA. It equals roughly the number of viral particles produced during
the single pulse. The definitions above result in the following dose reduction coefficient:
PS(λ∗) = ‖τ∗ μ
′∗ + τ ′∗ μ∗‖
‖τ∗ ( μ′∗ + κ σ ′∗) + τ ′∗ (μ∗ + κσ∗)‖
(50)
where
τ∗ = τ(λ∗) , τ ′∗ = ∇τ(λ)|λ=λ∗ (51)
Methods
Thus, the required key quantities are the average number of Tat molecules at this peak,
its standard deviation σmax(λ), and the typical time of the pulse duration scaled with the
expression rate τ(λ).
Themathematical description of noise: An overview of computing the mean and the
standard deviation
The mean and the standard deviation can be computed from a few lowest order facto-
rial moments of the particle number distribution function P(nA, nD, t) which specifies
the probability that the system will be found in a state (nA, nD) at time t. The factorial
moments are defined as
ρx,y(t) =
〈(nA
x
)
x!
(nD
y
)
y!
〉
(52)
where x and y are arbitrary positive integers, and the angular brackets denote the usual
ensemble average of an arbitrary function (observable) f (nA, nD),
〈f (nA, nD)〉 =
∑
nA,nD
f (nA, nD)P(nA, nD, t) (53)
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The mean and the variance are computed from the related factorial moments; ρx,y(t)
with x + y ≤ 2:
μA(t) = ρ1,0(t) (54)
μD(t) = ρ0,1(t) (55)
σ 2A(t) = ρ2,0(t) + ρ1,0(t)[ 1 − ρ1,0(t)] (56)
σ 2D(t) = ρ0,2(t) + ρ0,1(t)[ 1 − ρ0,1(t)] (57)
Of particular interest will be the values of μA(t) and σA(t) at t = ttmax . The equations of
motion for the factorial moments needed to compute these quantities are discussed in the
next section.
The equation system for factorial moments
By using the procedure detailed in [33,34], it is possible to show that the equation system
for the factorial moments is given by
ρ˙x,y(t) = αxρx−1,y+1(t)
+ (β + k)yρx+1,y−1(t)
+ kxyρx,y−1(t)
−[ (α + δ)y + βx] ρx,y(t)
(58)
In principle, such equation system forms an infinite hierarchy which for the present
system decouples automatically. It is known that when all propensity functions in the
stochastic formulation are linear with respect to the population count the computation of
statistical moments is simple. For example, the equations for ρ1,0 and ρ0,1 form a closed
system, and likewise the equations for ρ2,0, ρ0,2, and ρ1,1. It can be seen that the equations
for ρx,y with x+ y ≤ ξ form a closed system for every ξ = 1, 2, 3, · · · . This analysis implies
that the solution to a particular equation system is exact. Also, since the equation system
for factorial moments up to order ξ = 2 is exact, the values for the mean and the variance
will be exact.
Direct numerical integration should be avoided
In order to solve the equations it is necessary to integrate them from some initial
condition from time t=0 until t = tmax. There are several reasons why a direct
numerical integration should be avoided. First, the computational cost of a single
time integration scales linearly with the inverse of a typical time step size used. A
direct numerical integration is highly impractical, since to construct the phase dia-
grams, the noise measures have to be computed at many points in the reaction rate
space.
Second, there will be a need to compute derivatives of the mean and the standard devi-
ation with respect to the reaction rates. If obtained numerically, his would multiply the
computational effort by a factor two or more, depending on which technique is used to
numerically calculate the derivatives.
We have found a procedure to avoid the numerical integration and yet obtain an
analytic approximation of these quantities. The details of how μmax ≡ μA(tmax) and
σmax ≡ σA(tmax) are computed are given in the next section. Both quantities depend on
Konkoli and Jesorka Theoretical Biology andMedical Modelling 2013, 10:16 Page 15 of 28
http://www.tbiomed.com/content/10/1/16
ratios of the reaction rates. Accordingly, it is useful to re-scale all rates to obtain dimen-
sionless parameters, e.g., by rate α. This reduces the four dimensional Cartesian space
of reaction rates defined by tuples (α,β , δ, k) into a three-dimensional Cartesian space
defined by tuples (β¯ ≡ β/α, δ¯ ≡ δ/α, k¯ ≡ k/α). Thus,
μmax = fμ(β¯ , δ¯, k¯) (59)
σmax = fσ (β¯ , δ¯, k¯) (60)
where the functions fμ and fσ are detailed in the next section. When convenient the sub-
script “max” will be omitted. To simplify notation we will use only μ and σ instead of
μmax and σmax.
Details of computing the mean and the standard deviation
In this section it will be shown how to obtain the equations of motion for factorial
moments and the functional forms for the mean and the standard deviation.
A procedure for avoiding numerical integration
The numerical analysis of the equations of motion (not shown) suggests that the following
parameterization is useful:
ρ1,0(t) ≡ a(t) (61)
ρ0,1(t) ≡ d(t) (62)
ρ2,0(t) ≡ a(t)2 + a(t)(ϕA(t) − 1) (63)
ρ0,2(t) ≡ d(t)2 + d(t)(ϕD(t) − 1) (64)
ρ1,1(t) ≡
√
a(t)d(t)ϕAD(t) (65)
where ϕA and ϕD are the noise strengths for A and D particle types since it is trivial to see
that
σ 2A(t) = a(t)ϕA(t) (66)
σ 2D(t) = d(t)ϕD(t) (67)
The variable ϕAD(t) is a generalization of the noise strength concept for a pair of particle
types.
A numerical integration of the equations of motion shows that for large times η =
σ/μ → ∞ but, in the same limit, the noise strengths become constant,
lim
t→∞ ϕA(t) = ϕ
∗
A (68)
lim
t→∞ ϕD(t) = ϕ
∗
D (69)
lim
t→∞ ϕAD(t) = ϕ
∗
AD (70)
This can be used to obtain approximations for the noise strengths at t = tmax.
First, it is possible to construct an algebraic system of equations for these quantities
by studying the asymptotic limit of the ODE system for ϕA(t), ϕD(t) and ϕAD(t). This
implies that finding the asymptotic values for the noise strengths can be reduced to an
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algebraic problem. Second, for the Poisson initial condition the noise strengths are given
by
lim
t→0ϕA(t) = 1 (71)
lim
t→0ϕD(t) = 1 (72)
This can be seen from the fact that for the Poisson initial condition σ 2A(t = 0) = a(t =
0) and σ 2D(t) = d(t = 0) which after using the noise strength definitions (66) and (67)
automatically leads to the above result. Accordingly, given that the particle number distri-
bution function is Poisson-like at t ≈ 0, one can expect that ϕA(t) and ϕD(t) vary within
a finite interval.
A single cell can be infected by more than one virus particle. The number of viral
particles that infect a given cell (the multiplicity of infection) varies randomly and is usu-
ally Poisson-distributed. Accordingly, in what follows it will be assumed that the initial
particle number distribution function is Poisson-like.
With the assumptions at hand, the values of ϕ are known at two time instances,
around t=0 and t ≈ teq. Here and in the following teq denotes the time after
which the ϕ variables reach their asymptotic values. This information can be used
to obtain a very crude approximation for the noise strengths in the form of a lin-
ear interpolation between the points t=0 and t = teq. Once the interpolation has
been carried out, the values of the noise strengths at t = tmax are then given
by
ϕA(tmax) = 1 + (ϕ∗A − 1)
tmax
teq
(73)
ϕD(tmax) = 1 + (ϕ∗D − 1)
tmax
teq
(74)
This is the approximation that will be used to compute noise strengths at the time
instance where the number of the acetylated Tat particles reaches maximum.
There is no a priori reason why the noise strengths should vary linearly with time.
We have inspected several curves where noise strengths were computed numerically to
see whether the time dependence is linear. Interestingly, while the time dependence is
not strictly linear it seems that the approximation used is qualitatively correct. We per-
formed more rigorous tests of such an approximation by comparing it with the results of
a numerical integration for wide range of parameters and found reasonable agreement.
The time teq can be found (not shown) by computing the eigenvalues of the matrix
that defines the ODE system for the first and the second order moments. The smallest
eigenvalue governs the relaxation time which is given by
teq = 2q1 − q2 (75)
where
q1 = α + β + δ (76)
and
q2 =
√
q21 − 4(βδ − αk) (77)
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The equation system for noise strengths
By using the parameterization just introduced it is possible to obtain the equations of
motion for the means and the noise strengths. In addition, to make the analytic analysis
easier it is useful to map the means onto the Poincaré sphere:
a(t) = 1z(t) (78)
d(t) = u(t)z(t) (79)
This is a useful mathematical technique to perform asymptotic analysis (see [35] and
references therein). By using the new variables the equations for the means
a˙(t) = αd(t) − βa(t) (80)
d˙(t) = (β + k)a(t) − (α + δ)d(t) (81)
become
z˙(t) =[β − αu(t)] z(t) (82)
u˙(t) = β + k+[β − (α + δ)]u(t)
− αu(t)2 (83)
By combining (58) with (61-65) it is possible to obtain the equations for the noise
strengths that are given by
ϕ˙A(t) = 2α
√
u(t)ϕAD(t)
−[β + αu(t)] (ϕA(t) − 1) − 2αd(t) (84)
ϕ˙D(t) = 2 β + k√u(t)ϕAD(t) −
[
α + δ + β + ku(t)
]
×[ϕD(t) − 1]−2(β + k)a(t) (85)
ϕ˙AD(t) = α
√
u(t)[ϕD(t) − 1]
+ β + k√
u(t)
[ϕA(t) − 1]+ k√u(t)
−
[
α + β + δ + αu(t) + β + ku(t)
]
ϕAD(t)
2
+ αd(t)√u(t) + β + k√
u(t)
a(t) (86)
It will be shown later that the terms proportional to a(t) and d(t) also drop out in the
asymptotic limit when the stability condition is satisfied.
Locating the peak region
The value for tmax can be easily found by requiring that a˙(tmax) = 0. The equation system
(80-81) has to be solved with the initial condition a(0) = 0 and d(0) = d0 > 0 which
results in the expression for a(t) (not shown), the derivative of which is required to vanish.
This gives
tmax = 1q2 ln
q1 + q2
q1 − q2 (87)
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One can also find that
μmax = a(tmax) = d0 2αq1 + q2
(q1 + q2
q1 − q2
) 2q2
q1−q2 (88)
In order to see what happens when relatively few deacetylated Tat molecules are injected
the equation above will be used with d0 = 1.
Computing the asymptotic noise strengths
The equation (83) does not involve the variable z(t) and can be used to obtain the asymp-
totic value for the ratio d(t)/a(t) as time approaches infinity. This differential equation
has one stable fixed point in the physical region u(t)>0. The fixed point value for u(t), i.e.,
limt→∞ u(t) = u∗, is given by
u∗ =
√
(α − β + δ)2 + 4α(β + k) − (α − β + δ)
2α (89)
Note that there are no restrictions on the reaction rates, only that they are positive
real numbers. This implies that in this model the ratio of the number of acetylated and
deacetylated Tatmolecules approaches a constant value regardless on whether the system
is stable or not.
The asymptotic (fixed point) value of z(t) can be determined by considering how the
term β − αu(t) on the right hand side of Eq. (82) behaves as time becomes large. From
(89) one can see that
lim
t→∞[β − αu(t)]=
βδ − αk

(90)
where  is a strictly positive constant that depends on the values of the reaction rates. Its
exact numerical value is not relevant for the discussion and the formula for  will not be
shown. For large times one has
z(t) ∝ exp
[
βδ − αk

t
]
(91)
When βδ − αk > 0, z(t) grows exponentially fast, implying that the means approach
zero. This condition is fully equivalent to the stability condition (32). On the other hand,
when βδ−αk < 0, z(t) approaches zero exponentially fast, which implies that the average
copy numbers become infinite. In both cases the ratio of the means becomes constant
and is given by u∗.
For a stable system one can neglect the terms proportional to a(t) or d(t) in Eqs. (84-86)
when t → ∞. This results in a linear system of equations for the asymptotic values of the
noise strengths given by
2α
√
u∗ϕ∗AD = (β + αu∗)ϕ¯∗A (92)
β + k√
u∗
ϕ∗AD =
(
α + δ + β + ku∗
)
ϕ¯∗D
2 (93)[
α + β + δ + αu∗ + β + ku∗
]
ϕ∗AD
2
= α√u∗ϕ¯∗D +
β + k√
u∗
ϕ¯∗A +
k√
u∗
(94)
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where
ϕ¯∗A = ϕ∗A − 1 (95)
ϕ¯∗D = ϕ∗D − 1 (96)
Finally, σ can be computed as
σmax = σ(tmax) =
√
a(tmax)ϕ∗A (97)
where a(tmax) is given in (88) and ϕ∗A is obtained by solving (93-94). All algebraic equations
have been solved by using the Mathematica package (not shown).
Results
A hyperbolic coordinate system facilitates understanding
The space of the reaction rates is multi-dimensional and relatively hard to visualize.
Numerical tests showed that it is advantageous to re-parameterise the space of (β¯ , δ¯, k¯)
tuples by using the hyperbolic-like coordinate system,
β
α
= veu (98)
δ
α
= ve−u (99)
k
α
= v2(1 − ) (100)
Accordingly, an operating point will be the triple
λ = (v,u, ) (101)
In fact, this set of coordinates is very intuitive which can be appreciated by analysing the
meaning of the inverse transformation.
The coordinate v is given by
v = √βδ/α (102)
This quantity measures to which extent the reactions which remove acetylated Tat
dominate over the reaction that produces it. The coordinate
u = 12 ln
β
δ
(103)
measures the relative contribution of the reactions that remove acetylated Tat molecules.
These two coordinates naturally form a hyperbolic coordinate system. The variable
 = 1 − kα
βδ
(104)
is particularly important for several reasons. First, it measures how intensive the tran-
scription process (the production of acetylated Tat molecules) is. This coordinate also
measures how far in the ility region the operating point of the virus is placed. For exam-
ple,  = 0 at the border of the stab stability region when αk = βδ. Furthermore,  ≈ 1
when the stability condition is strongly satisfied, i.e. when βδ 
 kα. Thus, in the stable
region  attains values in the interval between zero and one.
This variable could potentially be used to experimentally quantify the degree of the
latency for a given cell. For example, the literature suggests that for a latent virus its oper-
ating point has to lie in the region of stability where  > 0. Otherwise, for  < 0, an
infected cell would lyse relatively fast. Thus, it seems necessary that a treatment meant
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to activate a latent virus has to move its operating point into the unstable region where
 < 0 or at least sufficiently close to the instability boundary  = 0.
An example of a typical operating point can be obtained from the resistor model. From
the experimental values [15] for the reaction rates αR = 0.5/day, βR = 5/day, δR = 2/day,
and kR = 5/day one can compute the corresponding operating point
λR = (6.325, 0.458, 0.750) (105)
The symbol “R” emphasizes the resistor model operating point.
Regions of parameter space where noise is large
Perhaps the biggest advantage with the hyperbolic coordinate system suggested is that the
v dependence is very easy to visualize. Figures 3a, 3b, and 3c depict how the coefficient
of variation η = σ/μ depends on the reaction rate parameters. Figures 3a and 3b demon-
strate that when  approaches the border of stability ( → 0) the coefficient of variation
approaches infinity. Figures 3b and 3c show that if v is increased, the coefficient of vari-
ation always increases, no matter which values for u and  are chosen. Figures 3a and 3c
indicate that if noise is to be exploited for a treatment, one should design drugs that could
move the operating point of the virus away from the regions around u ≈ 0. These plots
show in which regions of the parameter space the effects of noise are expected to domi-
nate. Superficial analysis of these figures would suggest that one should choose rates β and
δ as different as possible from each other, since this should increase the amount of noise
relative to the mean. However, in doing so one might move the operating point such that
despite the increase in fluctuations the threshold cannot be reached. A more quantitative
analysis is needed in order to identify useful noise-based strategies. This is illustrated by a
case study, where we suggest how the mathematical manual developed above can be used
to guide experimental design.
A case study: A strategy for improving noise-free histone deacetylase inhibitor treatment
by moving the operating point of the resistor system to a noisier region
A typical anti-latency strategy in the HIV therapy context is to increase the transcription
rate k, for example in treatments based on the use of histone deacetylase inhibitors [36].
These molecules open up the chromatin environment such that the transcription fac-
tors needed for viral expression can attach easier to their respective binging sites. Several
molecules have been suggested as drug candidates. Valproic acid, trichostatin A, vorino-
stat (SAHA), and many more have been reviewed in [36], and references therein. Some
of these molecules are rather toxic. In the following we investigate how toxicity could be
reduced by lowering their dosage at a typical operation point, e.g. λR. In order to anal-
yse the effects of various treatments it is useful to explicitly compute the gradients of the
mean and the standard deviation at this operating point.Wewill focus on the conceptually
simpler concentration-dependent threshold scenario.
The expressions for the derivatives are not shown. Their numerical values are given by:
μ′R = −(0.00808, 0.0161, 0.00911) (106)
σ ′R = −(0.0182, 0.0582, 0.0597) (107)
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Figure 3 Contour plots of σ/μ in three hyperplanes: (a) for (v = vR, u, ), (b) for (v, u = uR, ), and (c)
for (v, u,  = R). The position of the resistor model operating point is marked by the white circle. Contour
lines are labelled by their respective σ/μ values (square boxes). Lighter (darker) regions indicate where noise
does (does not) dominate the dynamics.
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By administering a certain amount of an anti-latent drug, e.g., SAHA, which only shifts kR
to kR + k and leaves αR, βR, and δR unchanged, the operating point would be shifted by
−→
λSAHA = (0, 0, 1) (108)
where is arbitrary but controlled by the amount of SAHA administered. From Eq. (26)
one can see that a more effective noise-based therapy with SAHA as the primary drug
exists, since PH(λR,−→λSAHA) = 0.087, which is smaller than one. From (25) one obtains
the exact value of the off-set that has to be achieved in order to produce the same gain in
the number of Tat molecules through noise-based therapy
˜λSAHA = (0.0219, 0.0618, 0.0573) (109)
Different changes in the reaction rates have to be used in order to generate these two
vastly different offsets. For example, let us investigate which changes in the transcription
rate k are needed to achieve the changes in (108) and (109).
From (98-100) follows that
β¯
β¯
= vv + u (110)
δ¯
δ¯
= vv − u (111)
k¯
k¯
= 2vv −

1 −  (112)
where β¯ = β/α, δ¯ = δ/α, and k¯ = k/α. For the noise-free treatment based on SAHA we
assume that
α = 0 (113)
β = 0 (114)
δ = 0 (115)
k > 0 (116)
In such a case the equations (110-112) and (113-116) imply that bothv andu are zero,
and the following relationship between k and  holds
k = −20 day−1 (117)
However, in the case of the noise-based therapy we do not know a priori the values for
˜α, ˜β , ˜δ, and ˜k. However, we do know that ˜v = 0.0219, ˜u = 0.0618, and
˜ = 0.0573. Again, for simplicity reasons we assume that ˜α = 0 which upon using
(110-112) gives the off-sets that need to be used in the noise-based treatment
˜β = 0.326 day−1 (118)
˜δ = −0.117 day−1 (119)
˜k = −1.11 day−1 (120)
By comparing (117) and (120) one sees that the dose of the primary drug can be reduced
roughly twenty times (assuming the linear relationship between the dose change and the
transcription rate change). The price one has to pay is that additional drugs have to be
administered which reduce β and increase δ (note that  is negative). It is not unreal-
istic that this can be eventually verified experimentally, e.g. in the context of the kinetics
experiments on LTR [14,15].
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Even if the optimal noise-free treatment would be applied in this case, noise-based
treatment would still result in dose reduction. An immediate use of Eq. (27) shows that
PH(λR) = 0.192.
Note that PH(λR,−→λSAHA) < PH(λR) since the SAHA therapy is not optimal. As the
optimal noise free (gradient based) therapy is more efficient than the SAHA treatment,
the corresponding noise based therapy would yield a smaller dose reduction.
This case study shows that it is sufficient to inspect the value of the dosage reduction
coefficient PH(λ) in order to test whether a noise-based treatment would be beneficial
at an operating point λ.
Regions of parameter space where noise-driven activation is possible
To identify regions in parameter space where noise-based activation is beneficial, we
determine how (λ) depends on the operating point for the two scenarios of interest.
The panels (a, d), (b, e), and (c, f ) in Figure 4 depict the contours of(vR,u, ),(v,uR, ),
and (v,u, R) for ( = PH,  = PS) respectively.
A striking result of this visual analysis is that regions where (λ) > 1 could
not be found within the hyperplanes. For both scenarios, we computed the dose
reduction coefficient for 10000 randomly selected operating points, and found always
 < 1. Moreover, for the PH scenario, at all points the angle between μ′∗ and σ ′∗
is always in the ±π/2 interval, i.e., the vectors point in roughly the same direc-
tion. It appears that the noise-based activation is advantageous everywhere, regardless
which value for κ is chosen. The degree of the dose reduction is clearly controlled
by κ . Note that the related graphs for (PH), (PS) are roughly the same, which
implies that the conclusion is generic. There are some differences that are worth dis-
cussing.
The contours in panels (a) and (d) differ in the middle region, and likewise for panels
(c) and (f ). There are even some regions where a relatively large dose reduction is possi-
ble. Figure 4a indicates that an efficient dosage reduction can be achieved in the regions
around u ≈ 0 where  is either very large or very small. This does not hold for panel (d).
However, both (a) and (d) panels suggest that the noise based therapy is advantageous in
the region where the absolute value of u is very large.
Figures 4b and 4e show that for fixed u the largest dose reduction can be reached for
very small values of  and very large values of v. Figures 4c and 4f indicate that the noise-
based activation can be useful in the regions where v is large and where either u → ∞ or
u → −∞. The panels do not agree in the middle region.
The linear theory yields qualitative predictions when operating point off-sets are not small
We provide a non-infinitesimal analysis for a particular operating point, and investigate
how it differs from the corresponding linear analysis. To do this we will use the technically
simpler PH scenario. This will be illustrated by studying how both μmax and μmax + σmax
depend on u and  for fixed v (Figure 5). One particular hyperplane has been chosen,
where the size of the u- and - components of the off-set in Eq. (109) is somewhat larger
than the v-component.
Several contour lines are shown: (NF1) μmax = μ1, (NF2) μmax = μ1 + N , (NB1)
μmax+σmax = μ1+σ1, and (NB2)μmax+σmax = μ1+σ1+N whereμ1 = 0.05378, μ1+
σ1 = 0.064536, and N = 0.010756.
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Figure 4 Phase diagrams for the dose reduction coefficient. The panels (a-c) and (e-f) depict contour
plots of the dose reduction coefficients PH(λ) and PS(λ) respectively. For both quantities three
hyperplanes are considered: (a) and (d) for (v = vR , u, ), (b) and (e) for (v, u = uR , ), (c) and (f) for
(v, u,  = R). The position of the resistor model operating point is marked by the white circle. In all plots for
lighter (darker) regions the dose reduction coefficient has relatively small (large) values. In lighter (darker)
regions the noise-based treatment is (not) advantageous over noise free treatment. For operating points that
are located in light regions the noise-based treatment can bring relatively large dosage reductions while in
the dark regions it might not be that advantageous if compared to a noise-free treatment.
The long black arrow denotes the linearized noise-free off-set that needs to be induced
in order to shift the mean from μmax to μmax + N . The long grey arrow is the shortest
non-infinitesimal noise-free off-set that needs to be induced to move from the operating
point to the NF2 contour line. The large grey circle (only in part visible) starts touching
NF2 exactly at the point where the arrow meets the contour line. The short black arrow
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Figure 5 Reaction rate dependence of μmax andμmax + σmax in a (u, ) hyperplane. Contour plots of
μmax and σmax + μmax in the (u, ) plane with v = vR . The full lines labelled NF1 and NF2 are two contours of
μmax, the two dashed lines labelled NB1 and NB2 are contours of σmax + μmax. The operating point of the
resistor model is represented by the white circle. The contour values for the NF1 and NB1 contours are
chosen so that these lines pass through the operating point of the resistor model. The contours labelled NF2
and NB2 have been off-set from NF1 and NB1 by the same N. The black arrows labelled
−→
λ are the
projections of the operating point offsets which need to be achieved in order to induce change in μmax and
μmax + σmax respectively by N. For comparison, the grey arrow labelled −→λ′ is the shortest possible path
from the operation point to NF2.
denotes the noise-based off-set that needs to be induced in order to shift μ + σ by N .
The small grey circle denotes the minimal circle that touches NB2.
The length ratio between the black vectors is specified exactly by the dose reduction
coefficient (λR) = 0.192. The grey arrow (the exact off-set) does not match its black
counterpart neither in length nor direction. Clearly, the size of the noise-free offset −→λ
needed to achieve the shift in μ is too large for the linearized version of the problem. This
approximation is more satisfactory for the noise-based treatment since the related noise-
based off-set ˜λ is still relatively small. The linearized theory provides qualitative results
for non-infinitesimal off-sets and that can be used in practise to guide future experiments.
A few comments on the robustness of the results with regard to the model extension
The model used in here cannot capture all phenomena that might be important. The first
feature of the model that can be clearly improved is its complexity. For example, we made
no distinction between mRNAs and proteins. It has been found that after integration into
the genome the HIV promoter makes mRNAs in random bursts of transcriptional activity
[37,38]. Moreover, each mRNA makes proteins in translational bursts. This suggests that
there might be other sources of noise in the system that were not considered in this work.
Also, a rather phenomenological model was used for the probability of activation and
the related observable. There is clearly a need for refinement. It is possible that the prob-
ability of the virus activation depends on other features of the system, e.g., the amount of
relative fluctuations. This is rather speculative, based upon indications in the literature
that Tat operates also outside the Tat feedback loop. Tat is a multi-functional protein that
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is involved in other intracellular processes [32,39,40] and there is certainly the possibil-
ity that it influences cell homeostasis in a more complex manner than discussed here. For
example, in addition to acetylation, Tat undergoes several other post-translational mod-
ifications and interacts with several other proteins. It is currently not entirely clear how
this might affect gene expression noise on one hand, and the activation probability on the
other. Post-translational modifications or other interactions could buffer, or propagate
noise in levels of Tat into noise in gene expression. The question remains whether such
effects could be beneficial in bringing the operating point closer to the stability boundary.
Out of all parameters in the model, such effects will very likely exert strong influence on
the decay constant δ of the deacetylated Tat and cause it to fluctuate in time. One could
speculate that in such a situation both u in v will start fluctuating, though u, being essen-
tially the natural logarithm of the ratio between β and δ, will fluctuate much less. This
implies that v fluctuates towards smaller values, away from the noise-rich regions, while u
and  are kept essentially constant (e.g. see the phase diagrams). Such changes in v could
reduce the activation probability, and need to be further investigated.
We now briefly discuss possible effects of chromatin on the operating point of a virus.
The transcription rate k will likely be influenced the most. This implies that instead
of analysing the effect of a drug on a single operating point one should investigated
a set of operating points. Such points should be distributed around the region where
v ≈ vR, u ≈ uR and where  ∈[ 0, 1]. Accordingly, a noise-based treatment designed to
move the operating point into a noisier region will work uniformly on all points in this
set. This would always result in a relatively large dose reduction; Figure 4, panels (a), (b),
(d) and (e).
Conclusions
We have designed a generic mathematical manual of how to approach the problem of
the HIV latency in a quantitative manner, accompanied by an example of how to use this
manual.We formalised several concepts that are vaguely defined or understood only intu-
itively. The first key concept is the notion of an “operating point” of the virus and how it is
affected by the action of a drug. The second key concepts of the mathematical formalism
is the notion of a particular observable that strongly affects the activation probability. We
suggested a mathematical way of describing how each therapy affects an operating point
and how this in turn influences the observable that controls the activation probability. The
third key ingredient is a dose reduction coefficient, which can be used to quantitatively
compare various therapies.
We have suggested and investigated two rather general strategies for the virus activa-
tion, the noise-free and the noise-based strategy. In the first approach, anti-latency agents
are administered such that the activation happens with almost absolute certainty. In order
to achieve such certainty, possibly unreasonable quantities of drugs need to be adminis-
tered. In the second approach, drugs are administered in such a way that the activation is
less certain but still happens with a relatively large probability. The idea behind the noise-
based strategy is to reduce the quantity of drugs that need to be administered in order to
achieve activation.
The mathematical manual is rather generic. To demonstrate how the mathematical
manual can be used, we have focused on the simplest possible model of the Tat pro-
tein feedback loop, the most important part of the the HIV latency control. Based on the
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structure of the loop we suggested a class of noise-based activation strategies. We envi-
sion such an activation strategy in a procedure where one constantly supplies exogenous
Tat at a very small rate, and adds a combination of anti-latency drugs that would off-set
the operating point of the virus towards noisier regions.
In this context we considered two observables and could compute the dose reduction
coefficient for both cases to answer the fundamental question: for which operating points
the noise-base therapy is advantageous over the noise-free therapy in the sense of possible
dosage reduction? This addresses the practical problem of reducing effects of toxicity
during the anti-latent treatment. Three phase diagrams were constructed to explain what
controls the noise, and how this control can be used to battle latency. Our analysis of the
phase diagrams indicates that the noise-based therapy is always advantageous, no matter
which operating point the virus adopts. This results holds regardless of which observable
is targeted. This is the major result of our analysis.
The mathematical manual is currently based on rather qualitative assumptions, but it
is very generic and can be easily extended and refined. For example, we have used the
assumption of small operating point offsets in order to linearize the theory. One can easily
consider non-infinitesimal off-sets, as demonstrated in the example.We discussed several
possible extensions which are left for future work.
In summary, we suggest an activation principle where intrinsic noise is considered a
feature benefiting treatment. We showed that such strategy should be efficient for any
latent cell.
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